PeptidePedia The community reference

Syringe dead space: difference between revisions

Diff·revision 44 → 45·04:29, 23 Feb 2026

Difference between revision 44 and revision 45 of Syringe dead space. 2 lines changed; the page grew by 347 bytes.

Revision 44 — 11:27, 16 Feb 2026
StubSorterBot (talk)
bot: add stub category
19,938 bytes +557
Revision 45 — 04:29, 23 Feb 2026
TFA_Counterion (talk)
expand §Terminology and reporting problems
20,285 bytes +347
142The first is the conflation described above: a dead-space volume is quoted as though it were automatically a dose error. It is only a dose error under a specific condition — gas occupying the dead space when the dose is measured — and the condition is often left implicit.142The first is the conflation described above: a dead-space volume is quoted as though it were automatically a dose error. It is only a dose error under a specific condition — gas occupying the dead space when the dose is measured — and the condition is often left implicit.
143143
+144The second is the use of dead space as a device-quality claim. A device may be marketed on a low retained volume without stating how the figure was obtained, and because no standard requires the declaration, no comparability can be assumed. Marketing figures and gravimetrically measured figures for the same product have differed.{{r|zule2013}}
+145
144== References ==146== References ==
145{{reflist}}147{{reflist}}